A rapid and sensitive HPLC-APCI-MS/MS method determination of fluticasone in human plasma: application for a bioequivalency study in nasal spray formulations.

[1]  R. Baker,et al.  Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations. , 2008, British journal of clinical pharmacology.

[2]  Howard S. Herman.  Once-Daily Administration of Intranasal Corticosteroids for Allergic Rhinitis: A Comparative Review of Efficacy, Safety, Patient Preference, and Cost , 2007, American journal of rhinology.

[3]  Y. Yin,et al.  Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays , 2004, European Journal of Clinical Pharmacology.

[4]  A. Maw,et al.  Intranasal steroid sprays in the treatment of rhinitis: is one better than another? , 2003, The Journal of Laryngology & Otology.

[5]  P. Daley-Yates,et al.  Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. , 2001, British journal of clinical pharmacology.

[6]  Adnan Custovic,et al.  Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study , 2000, The Lancet.

[7]  H. Möllmann,et al.  A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma. , 2000, Journal of pharmaceutical and biomedical analysis.

[8]  J. Oxford,et al.  An improved method for the determination of fluticasone propionate in human plasma. , 1999, Journal of pharmaceutical and biomedical analysis.

[9]  A. Jones,et al.  Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography-tandem mass spectrometry. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[10]  K. Brown,et al.  A sensitive method for the quantification of fluticasone propionate in human plasma by high-performance liquid chromatography/atmospheric pressure chemical ionisation mass spectrometry. , 1997, Journal of pharmaceutical and biomedical analysis.

[11]  D. Faulds,et al.  Triamcinolone Acetonide , 2012, Drugs.

[12]  M. Johnson,et al.  Fluticasone propionate--an update on preclinical and clinical experience. , 1995, Respiratory medicine.

[13]  G. Hopfgartner,et al.  Quantitative high-throughput analysis of drugs in biological matrices by mass spectrometry. , 2003, Mass spectrometry reviews.

[14]  D. Faulds,et al.  Triamcinolone acetonide. A review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. , 1997, Drugs.